| |
| |
|
| Insider
Information: |
Leiden Jeffrey M |
| Relationship: |
Director |
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
229,179 |
|
|
Indirect Shares
|
8,575 |
|
|
| Direct
Value |
$30,015,965 |
|
|
|
Indirect Value
|
$280,899 |
|
|
| Total
Shares |
237,754 |
|
|
| Total
Value |
$30,296,865 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
President and COO, Dir... |
2006-03-24 |
209,401 |
2006-03-24 |
635 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Executive Chairman, Di... |
2024-02-20 |
13,778 |
2024-02-20 |
440 |
Premium* |
|
|
Quest Diagnostics Inc |
DGX |
Director |
2018-05-29 |
6,000 |
2014-12-01 |
0 |
Premium* |
|
|
Revolution Healthcare Acquisitio... |
REVH |
Director |
|
0 |
2021-03-17 |
7,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DGX |
Quest Diagnostics Inc |
Director |
– • – |
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,573 |
7,600 |
0 |
- |
|
| DGX |
Quest Diagnostics Inc |
Director |
– • – |
2017-07-27 |
4 |
S |
$108.73 |
$141,783 |
D/D |
(1,304) |
6,296 |
0 |
- |
|
| DGX |
Quest Diagnostics Inc |
Director |
– • – |
2017-08-04 |
4 |
S |
$106.66 |
$31,571 |
D/D |
(296) |
6,000 |
0 |
- |
|
| DGX |
Quest Diagnostics Inc |
Director |
– • – |
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
7,644 |
0 |
- |
|
| DGX |
Quest Diagnostics Inc |
Director |
– • – |
2018-05-29 |
4 |
S |
$105.61 |
$173,623 |
D/D |
(1,644) |
6,000 |
0 |
- |
|
| REVH |
Revolution Healthcare Acq... |
Director |
– • – |
2021-03-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,500 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-03-31 |
4 |
D |
$234.01 |
$9,381,461 |
D/D |
(40,090) |
52,491 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-05-05 |
4 |
OE |
$91.05 |
$12,175,273 |
D/D |
88,537 |
141,028 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-05-05 |
4 |
AS |
$265.57 |
$25,475,037 |
D/D |
(94,372) |
46,656 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-05-07 |
4 |
OE |
$91.05 |
$12,174,982 |
D/D |
88,534 |
135,190 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-05-07 |
4 |
AS |
$267.52 |
$25,459,013 |
D/D |
(94,369) |
40,821 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-05-12 |
4 |
OE |
$91.05 |
$12,174,639 |
D/D |
88,532 |
129,353 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-05-12 |
4 |
AS |
$277.14 |
$26,751,440 |
D/D |
(94,370) |
34,983 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2020-06-30 |
4 |
AS |
$284.14 |
$9,383,304 |
D/D |
(32,792) |
2,261 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
83,888 |
86,199 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2021-02-03 |
4 |
D |
$215.03 |
$1,849,043 |
D/D |
(8,599) |
77,600 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2021-02-10 |
4 |
D |
$214.16 |
$2,988,389 |
D/D |
(13,954) |
63,646 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2021-02-17 |
4 |
D |
$211.75 |
$2,958,148 |
D/D |
(13,970) |
49,676 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
66,817 |
116,605 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-02-02 |
4 |
D |
$243.63 |
$1,529,753 |
D/D |
(6,279) |
110,326 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-02-17 |
4 |
D |
$232.51 |
$1,914,952 |
D/D |
(8,236) |
102,090 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-02-24 |
4 |
D |
$227.86 |
$2,766,448 |
D/D |
(12,141) |
89,949 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-04-13 |
4 |
AS |
$289.04 |
$4,563,653 |
D/D |
(15,789) |
74,160 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-07-25 |
4 |
AS |
$279.44 |
$37,164,481 |
D/D |
(132,079) |
2,423 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Executive Chairman |
• • – |
2022-07-25 |
4 |
OE |
$91.05 |
$5,494,139 |
D/D |
60,342 |
134,502 |
0 |
- |
|
136 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
